The expression of DLGAP5 associate with progression and prognosis in glioma
<p>Glioma is the most common primary malignant tumor of the central nervous system and is related to poor clinical outcomes. At present, the standard treatment of glioma in clinical practice is to maximally remove the focus on the premise of protecting the neurological function, supplemented b...
Saved in:
Main Authors: | Kangjie Du (Author), Yu Zhang (Author), Mengyao He (Author), Yalin Lu (Author), Xingjie Chen (Author), Hao Yu (Author), Qiang Huang (Author) |
---|---|
Format: | Book |
Published: |
Annals of Molecular and Genetic Medicine - Peertechz Publications,
2022-11-09.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DLGAP1 directs megakaryocytic growth and differentiation in an MPL dependent manner in hematopoietic cells
by: Boguslaw A. Kwiatkowski, et al.
Published: (2019) -
URB2 as an important marker for glioma prognosis and immunotherapy
by: Chaoyou Fang, et al.
Published: (2023) -
Research Progress on the Mechanism of Histone Deacetylases in Ferroptosis of Glioma
by: Meng Ma, et al.
Published: (2024) -
Correlation of microrna-372 upregulation with poor prognosis in human glioma
by: Li Gang, et al.
Published: (2013) -
Lost expression of ADAMTS5 protein associates with progression and poor prognosis of hepatocellular carcinoma
by: Li C, et al.
Published: (2015)